AGEPC is dedicated to improving the social and economic conditions of people living with hepatitis B and C, with the goal of increasing their life expectancy. The organization seeks to drive government and public policy changes that emphasize prevention, diagnostics, and timely access to modern treatments for individuals affected by these infections.
AGEPC advocates for the rights of people living with hepatitis B and C by lobbying for improved access to treatment and legal protections. The organization works to combat discrimination, raise awareness among key stakeholders, and strengthen the capacity of regional NGOs. It also provides training for patients and healthcare professionals while fostering community engagement through cultural and social activities. Additionally, AGEPC collaborates with international organizations to enhance treatment opportunities and medical expertise in Kazakhstan.